Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy.

被引：0
|
作者：
Ghidini, Michele
Hahne, Jens Claus
Senti, Chiara
Tomasello, Gianluca
Ratti, Margherita
Heide, Timon
Garrone, Ornella
Cortellini, Alessio
Passalacqua, Rodolfo
Valeri, Nicola
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Med Oncol, Milan, Italy
[2] Inst Canc Res, London, England
[3] Hosp Cremona, Div Med Oncol, ASST Cremona, Cremona, Italy
[4] Human Technopole, Milan, Italy
[5] Imperial Coll London, Div Surg & Canc, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
175
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [31] Clinical application of circulating tumor DNA (ctDNA) in patients with metastatic gastric cancer.
    Hong, Moonki
    Lee, Kwang Seob
    Park, Sejung
    Kim, Kyoo Hyun
    Kim, Hyunwook
    Che, Jingmin
    Kwon, Woo Sun
    Lee, Choong-kun
    Jung, Minkyu
    Chung, Hyun Cheol Cheol
    Shin, Saeam
    Lee, Seung-Tae
    Choi, Jong Rak
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 441 - 441
  • [32] PK/PD analyses of circulating tumor DNA (ctDNA) in patients with metastatic colorectal cancer (mCRC) treated with telisotuzumab adizutecan (ABBV-400).
    Abdelgawad, Ibrahim
    Vasilopoulos, Athanasios
    Neagu Aristide, Martha Raluca
    Freise, Kevin Jay
    Parikh, Apurvasena
    Biesdorf de Almeida, Carla
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 233 - 233
  • [33] Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)?
    Loree, Jonathan M.
    Bubie, Adrian
    Strickler, John H.
    Drusbosky, Leylah
    Kopetz, Scott
    Raghav, Kanwal Pratap Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Loco-Regional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancer Patients Undergoing Front-Line Chemotherapy
    Tinterri, Corrado
    Sagona, Andrea
    Barbieri, Erika
    Di Maria Grimaldi, Simone
    Jacobs, Flavia
    Zambelli, Alberto
    Trimboli, Rubina Manuela
    Bernardi, Daniela
    Vinci, Valeriano
    Gentile, Damiano
    CANCERS, 2022, 14 (24)
  • [35] Serial circulating tumor DNA (ctDNA) monitoring in metastatic colorectal cancer (mCRC) reveals dynamic profile of actionable alterations.
    Loree, Jonathan M.
    Henry, Jason
    Raghav, Kanwal Pratap Singh
    Parseghian, Christine Megerdichian
    Banks, Kimberly
    Raymond, Victoria M.
    Nagy, Rebecca
    Hensel, Chuck
    Strickler, John H.
    Corcoran, Ryan Bruce
    Overman, Michael J.
    Talasaz, AmirAli
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Chemotherapy efficacy in metastatic colorectal cancer (mCRC) patients treated with adjuvant or first-line FOLFOX-based chemotherapy.
    Samalin, Emmanuelle
    Tien Tuan Nguyen
    Thezenas, Simon
    Portales, Fabienne
    Mazard, Thibault
    Gourgou, Sophie
    Assenat, Eric
    Ychou, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Virologic response to HAART in AIDS-related lymphoma patients undergoing front-line chemotherapy.
    Lieberman, RD
    Tulpule, A
    Espina, BM
    Seneviratne, L
    Levine, AM
    BLOOD, 2002, 100 (11) : 469A - 470A
  • [38] Exploring the prognostic and predictive value of circulating tumor DNA in patients with advanced colorectal cancer and chemotherapy.
    Liu, Xiu
    Zhang, Xuan
    Ou, Kai
    Lu, Chelong
    Zheng, Dong
    Liu, Jun
    Xu, Qiang
    Yang, Lin
    CANCER RESEARCH, 2021, 81 (13)
  • [39] Circulating tumor DNA is capable of monitoring the therapeutic response and resistance in advanced colorectal cancer patients undergoing combined target and chemotherapy.
    Cao, Hua
    Liu, Xinyi
    Chen, Yixin
    Yang, Pan
    Huang, Tanxiao
    Song, Lele
    Xu, Ruilian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Prognostic factors of patients (pts) with salvage-line metastatic colorectal cancer (mCRC)
    Bando, Hideaki
    Oki, Eiji
    Takeda, Yuriko
    Misumi, Toshihiro
    Suzuki, Motoko
    Wakabayashi, Masashi
    Yamazaki, Kentaro
    Grothey, Axel
    Mayer, Robert J.
    Li, Jin
    Andre, Thierry
    Shi, Qian
    De Gramont, Aimery
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 115 - 115
12345